Anthrax vaccine program and related assets and technology. The portfolio includes all assets and rights related to a recombinant protective antigen (rPA) anthrax vaccine product.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Vaxgen (Anthrax Vaccine Assets and Technology)‘s full profile, request access.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Vaxgen (Anthrax Vaccine Assets and Technology)‘s full profile, request access.
Request a free trial